by Danielle Bonadies | Dec 1, 2014 | Genetic Journal
It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop breast cancer (50-85% lifetime risk) and ovarian cancer (15-60% lifetime risk). Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test...
by Danielle Bonadies | Nov 3, 2014 | Genetic Journal
Earlier this month, singer/songwriter Melissa Etheridge appeared on the Dr. Oz show to discuss her 10-year breast cancer survivorship, her BRCA+ status, and her views on cancer development. Etheridge reiterated her views on prophylactic surgery for BRCA carriers,...
